Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Ct Photoncounting

Related Conditions

Often studied with 9 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07790614Recruiting

Photon-counting CT Scan vs Standard HRCT Scan in the Identification of Idiopathic Pulmonary Fibrosis

NCT05838482CompletedPrimary

Clinical Feasibility and Evaluation of Silicon Photon Counting CT

NCT04781296Not ApplicableCompletedPrimary

Spectral CT With Advanced CT Technology

Showing all 3 trials

Research Network

Common Treatments

  • Ct Photoncounting1
  • Ct With A Photoncounting Detector1
  • Photon Counting Ct1

Active Sponsors

  • GE Healthcare2
  • Istituto Clinico Humanitas1
  • Stanford University1
  • Prismatic Sensors AB1

Top Investigators

Related Conditions

  • Idiopathic Pulmonary Fibrosis Ipf1
  • Ct1
  • Ct Scan1
  • Idiopathic Pulmonary Fibrosis1
  • Interstitial Lung Diseases1

Activity Timeline